Now Offering RT-PCR Testing with Results in 1 hour!
We NOW OFFER RT-PCR Testing with Results in 1 hour!
How does it work?
All testing is performed outside of the pharmacy, with parking in front of the pharmacy in any of the 15 minute parking spots. When you arrive at the pharmacy, please call our main line at 619-303-7771 and someone will be right out to assist.
Once you arrive our staff member will provide you with the testing kit. You will be instructed on the steps needed to complete the test. The test is an anterior nasal swab (it is inserted only at the tip of the nose). The test is completely self-contained – no mixing of fluids or complex testing procedure required. Once the swab is performed our staff will send your results via e-mail OR you may pick up your results once they are ready. Results may be ready in as little as 1 hour.
What is the age requirement for testing?
The minimum age for testing is 2 and above.
What is the Turn Around Time (When should I expect my results)?
The estimated turnaround time is 1 hour. Results will be sent via e-mail (or may choose to pick up) with same day results. If your results are NOT needed in 1 hour we offer additional turn around times. Please refer to "What is the cost of the PCR" for additional information on turn around times.
Is the Lab CLIA-certified?
Yes, our pharmacy has a CLIA waiver.
Is the test FDA approved?
The kit has an emergency authorization use by the FDA.
What is the cost of the PCR?
The cost varies on how soon you need your results.
Results within 48 hours is $175.
Results within 24 hours is $199.
Results within 1 hour is $329.
Do you accept health insurance?
At this time, we do not directly bill health insurance. We will be glad to provide you with a detailed receipt that you may wish to turn into your insurance to seek possible reimbursement.
Will it meet my travel requirements?
Due to ongoing changes and differences between airlines/countries/states requirement, we cannot assure that your results will be accepted for specific travel requirements. We recommend that you reach out to your airline/country for exact requirements and if the test RT-PCR test offered by Rancho Pharmacy will meet those requirements.
Does your test meet the requirements for Hawaii?
No our test will NOT be sufficient for travel to Hawaii.
I received a negative test what does this mean?
The Cue COVID-19 Test is a U.S. FDA Emergency Use Authorized molecular nucleic acid amplification test (NAAT) that detects the genetic material of SARS-CoV-2 using a molecular amplification reaction that is an equivalent amplification method to molecular polymerase chain reaction (PCR). A Negative result means that Cue COVID-19 Test did not detect SARS-CoV-2 virus in your sample.
How do I register?
You may register online on our website under COVID testing. Make sure to select PCR when choosing what type of the test. We also recommend you remind our staff member the type of test you wish to have performed.
What does it mean if the specimen tests negative for the virus that causes COVID-19?
A negative test result for this test means that SARS- CoV-2 RNA was not present in the specimen above the limit of detection. However, a negative result does not rule out COVID-19 and should not be used as the sole basis for treatment or patient management decisions. It is possible to test a person too early or too late during COVID-19 infection to make an accurate diagnosis via Cue COVID-19 Test.
In addition, asymptomatic people infected with COVID- 19 may not shed enough virus to reach the limit of detection of the test, giving a false negative result. In the absence of symptoms, it is difficult to determine if asymptomatic people have been tested too late or too early. Therefore, negative results in asymptomatic individuals may include individuals who were tested too early and may become positive later, individuals who were tested too late and may have serological evidence of infection, or individuals who were never infected.
When diagnostic testing is negative, the possibility of a false negative result should be considered in the context of a patient’s recent exposures and the presence of clinical signs and symptoms consistent with COVID-19. The possibility of a false negative result should especially be considered if the patient’s recent exposures or clinical presentation indicate that COVID- 19 is likely, and diagnostic tests for other causes of illness (e.g., other respiratory illness) are negative. If COVID-19 is still suspected based on exposure history together with other clinical findings, re-testing with an alternative method should be considered by healthcare providers in consultation with public health authorities. Additional testing may be helpful to ensure testing was not conducted too early.
Risks to a patient of a false negative test result include: delayed or lack of supportive treatment, lack of monitoring of infected individuals and their household or other close contacts for symptoms resulting in increased risk of spread of COVID-19 within the community, or other unintended adverse events.
The performance of this test was established based on the evaluation of a limited number of clinical specimens. The clinical performance has not been established in all circulating variants but is anticipated to be reflective of the prevalent variants in circulation at the time and location of the clinical evaluation. Performance at the time of testing may vary depending on the variants circulating, including newly emerging strains of SARS- CoV-2 and their prevalence, which change over time.
What does it mean if the specimen tests positive for the virus that causes COVID-19?
A positive test result for COVID-19 indicates that RNA from SARS-CoV-2 was detected, and therefore the patient is infected with the virus and presumed to be contagious.
Test results should always be considered in the context of clinical observations and epidemiological data in making a final diagnosis and patient management decisions. Patient management should be made by a healthcare provider and follow current CDC guidelines.
The Cue COVID-19 Test has been designed to minimize the likelihood of false positive test results. However, in the event of a false positive result, risks to patients could include the following: a recommendation for isolation of the patient, monitoring of household or other close contacts for symptoms, patient isolation that might limit contact with family or friends and may increase contact with other individuals with COVID-19, limits in the ability to work, the delayed diagnosis and treatment for the true infection causing the symptoms, unnecessary prescription of a treatment or therapy, or other unintended adverse effects.
#PCR#RT-PCR#NAAT#testign#covid-19
Now Offering Strep Testing, with results in 5 minutes!
Why is it important to test for Strep?
Rapid diagnosis and early antibiotic therapy for Group A Streptococcal infection are the best means of preventing medical complications and reducing the spread of the disease.
Group A Strep is a bacterial infection common in school-age children (with limited cases in infants and older adults) that is generally experienced in the United States during winter and spring.
Streptococcus pyogenes is a gram-positive coccus, which contains the Lancefield group A antigen that can cause serious infections such as pharyngitis, respiratory infection, impetigo, endocarditis, meningitis, puerperal sepsis, and arthritis. Left untreated these infections can lead to serious complications, including rheumatic fever and peritonsillar abscess. Traditional identification procedures for group A streptococcal infection involve the isolation and identification of viable organisms using techniques that require 24 to 48 hours or longer.
Rapid diagnosis and early antibiotic therapy of group A streptococcal infection appear to be the best means of preventing medical complications and reducing the spread of the disease.
What type of testing is offered by Rancho Pharmacy?
Group A Streptococcus rapid antigen testing is a digital immunoassay that quickly efficiently and reliably detects the presence of Group A Strep antigen from throat swabs of patients suspected of having Group A Strep. It is a qualitative test that detects the presence of Strep A antigen in throat swab specimens from symptomatic patients, providing results within 5 minutes.
The test is a simple throat swab sample collection with fast, reliable results in as few as 5 minutes.
The test utilizes antibodies specific for whole cell Lancefield group A Streptococcus to selectively detect Strep A antigen.
What is the sensitivity of the test?
Sensitivity measures the ability of the test to appropriately make a positive identification. The test has a high sensitivity rate of 95.4%, resulting in fewer false negatives.
What is the specificity rate?
Specificity measures the ability of the test to properly identify the absence of the test target. The test has a high specificity rate of 95.7%, resulting in fewer false positives.
What happens if I receive a positive test?
If you receive a positive test you should immediately contact your doctor. If you would like our pharmacy to contact your doctor please let the pharmacist know so that we may coordinate with your provider. Your doctor will decide on how to proceed further and may choose to prescribe an antibiotic. If your doctor prescribes an antibiotic our pharmacy is happy to assist with filling your prescription.
What is the cost of the test?
The test costs $30. At this time, we are unable to accept insurance however we are more than happy to provide you with receipt so you may attempt to seek reimbursement from your insurance.
Now offering 10 minute FLU A + B Testing!
Now offering 10 minute FLU A + B Testing!
Influenza illness classically presents with sudden onset of fever, chills, headache, myalgias, and a non-productive cough. Epidemics of influenza typically occur during winter months with estimated 114,000 hospitalizations and 36,000 deaths per year in the U.S.
Influenza viruses can also cause pandemics, during which rates of illness and death from influenza-related complications can increase dramatically. Patients who present with suspected influenza may benefit from treatment with an antiviral agent especially if given within the first 48 hours of onset of illness. It is important to rapidly distinguish influenza A from influenza B in order to allow physicians a choice in selective antiviral intervention. Moreover, it is important to determine if influenza A or B is causing symptomatic disease in a particular institution (e.g., nursing home) or community, so that appropriate preventative intervention can be taken for susceptible individuals. It is therefore important to not only rapidly determine whether influenza is present, but also which type of influenza virus is present as severity and treatment can be different.
What type of testing is offered by Rancho Pharmacy?
Rancho Pharmacy uses a 10 minute testing kit developed by BD. The system is called BD Veritor System for Rapid Detection of Flu A+B. The test is FDA-Cleared Rapid Influenza Diagnostic Test (Antigen Detection Only).
The BD Veritor System for Rapid Detection of Flu A+B (also referred to as the BD Veritor System and BD Veritor System Flu A+B) is a digital immunoassay (DIA) to qualitatively detect influenza A or B nucleoprotein antigens from respiratory specimens of symptomatic patients with a time to result of 10 minutes. The test is qualitative and not quantitative, meaning it can only indicate if influenza A or B is present in the sample collected, but not how much influenza is present.
What may cause a false positive?
Per the manufacturer FluMist® is made from attenuated live flu virus and although the concentration tested (1%) was non-interfering, it is possible when tested with higher concentrations that an influenza A and/or influenza B false positive may occur.
What happens if I receive a positive test?
Regardless if you receive a positive or negative test it is highly recommended to call your physician to receive an evaluation. The pharmacy will provide you with your results and if asked by the patient or legal guardian may offer to call the physician if a medication may be warranted. Tamiflu is a medication that is indicated for influenza for the treatment of acute, uncomplicated illness due to influenza A and B infection in patients 2 weeks of age or older who have been symptomatic for no more than 48 hours. Tamiflu is indicated for prophylaxis of influenza A and B in patients 1 year and older.
